| Old | New | Differences | |
|---|---|---|---|
| 1 | 1 | ||
| 2 | 2 | ||
| 3 | 3 | HB 2945 2022 | |
| 4 | 4 | ||
| 5 | 5 | ||
| 6 | 6 | ||
| 7 | 7 | CODING: Words stricken are deletions; words underlined are additions. | |
| 8 | 8 | hb2945-00 | |
| 9 | 9 | Page 1 of 1 | |
| 10 | 10 | F L O R I D A H O U S E O F R E P R E S E N T A T I V E S | |
| 11 | 11 | ||
| 12 | 12 | ||
| 13 | 13 | ||
| 14 | 14 | A bill to be entitled 1 | |
| 15 | 15 | An act relating to the Appropriations Project titled 2 | |
| 16 | 16 | Department of Children and Families (DCF) Extended -3 | |
| 17 | 17 | Release Injectable Naltrexone (Vivitrol) Program ; 4 | |
| 18 | 18 | providing an appropriation; providing an effective 5 | |
| 19 | 19 | date. 6 | |
| 20 | 20 | 7 | |
| 21 | 21 | Be It Enacted by the Legislature of the State of Florida: 8 | |
| 22 | 22 | 9 | |
| 23 | 23 | Section 1. Department of Children and Families (DCF) 10 | |
| 24 | 24 | Extended-Release Injectable Naltrexone (Vivitrol) Program is an 11 | |
| 25 | 25 | Appropriations Project as defined in The Rules of The Florida 12 | |
| 26 | 26 | House of Representatives and is described in Appropriations 13 | |
| 27 | 27 | Project Request 536, herein incorporated by reference. 14 | |
| 28 | 28 | Section 2. For fiscal year 2022-2023 the nonrecurring sum 15 | |
| 29 | 29 | of $796,706 from the General Revenue Fund is appropriated to the 16 | |
| 30 | 30 | Department of Children and Families to fund the Department of 17 | |
| 31 | 31 | Children and Families (DCF) Extended -Release Injectable 18 | |
| 32 | 32 | Naltrexone (Vivitrol) Program as described in Appropriations 19 | |
| 33 | 33 | Project Request 536. 20 | |
| 34 | 34 | Section 3. This act shall take effect July 1, 2022. 21 |